ArticleChemistry, an Asian journal2025
Nickel Hydroxide/Carbon Dot Nanocomposites as Effective Antibacterial Agents.
Article in Chemistry, an Asian journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Antibiotic-resistant bacterial strains are an ever-present hurdle for human health. A route to overcoming this threat is the development of effective antimicrobial agents based on carbon-supported nanocomposites. In this study, carbon dots (CD) are synthesized by a facile hydrothermal treatment of ethylenediaminetetraacetic acid and melamine and further functionalized with nickel hydroxide colloids. Whereas CD alone exhibits virtually no antimicrobial activity under photoirradiation at 365 nm against Escherichia coli in comparison to the blank control, the performance is markedly enhanced with the Ni(OH)
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.